Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Dyadic International Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 38 | 38 | 0 |
| Shares | 5.87M | 5.57M | −301.0K (−5.1%) |
| Value | $6.93M | $5.24M | −$1.69M (−24.4%) |
New holders (4)
Institutions that held Dyadic International Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 20,761 | $19.5K | 0.00% |
| Traphagen Investment Advisors LLC | 13,000 | $12.2K | 0.00% |
| Royal Bank of Canada | 691 | $1.00K | 0.00% |
| Citigroup Inc | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held Dyadic International Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| CI Private Wealth, LLC | 250,000 | $295.0K |
| Jane Street Group, LLC | 19,249 | $22.7K |
| Citadel Advisors LLC | 13,034 | $15.4K |
| Group One Trading, L.P. | 1,500 | $1.77K |